RxDoctor Payments Data

Ngoc-Lam Nguyen, MD

Orthopaedic Surgery of the Spine · Sarasota, FLNPI 1508181769

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (49.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Innovasis Inc at 56.3% of the total.

$346,317in general payments, 2019–2025

Across 308 payments — averaging $1124.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Innovasis Inc$195K
  • Medical Device Business Services, Inc.$76K
  • Expanding Innovations, Inc.$29K
  • Johnson & Johnson$10K
  • L&k Spine Inc$8K
  • Pacira Pharmaceuticals Incorporated$7K
  • plus $22K from 17 others
$28,048in ownership & investment interests, 2019–2025

Across 4 payments — averaging $7011.88 each. An ownership or investment interest held by the physician or an immediate family member.

  • Expanding Innovations, Inc.$28K

What the payments were for

  • Consulting fees$139,64540%
  • Speaking & faculty fees$172,28550%
  • Travel & lodging$21,8036%
  • Food & beverage$12,4824%
  • Education$650%
  • Other$370%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$346,317 in reported general payments places this provider in the 85th percentile of 159 orthopaedic surgery of the spine providers in Florida.

See all orthopaedic surgery of the spine providers in Florida

Medicare billing

Part B allowed, 2024
$1,529,011
Medicare patients
1,847
Services billed
8,617

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin486$4,002
Methocarbamol256$3,040
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen147$2,046
Oxycodone Hcl232$1,703
Pregabalin103$1,676
Methylprednisolone236$1,500
Tizanidine Hcl103$979
Cyclobenzaprine Hcl54$906
Tramadol Hcl198$794
Ondansetron OdtOndansetron52$733
Celecoxib37$578
Hydromorphone Hcl43$272
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$241
Meloxicam112$184
Diclofenac Sodium15$184

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Sarasota

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →